Quick Summary Scientists have engineered probiotic bacteria (E. coli Nissle 1917) to locate tumors and produce the cancer drug romidepsin directly inside the tumor microenvironment. In mouse models, this approach slowed tumor growth and may offer a more precise targeted therapy with fewer side effects than traditional chemotherapy. How it
Quick Summary Uterine cancer treatment typically involves surgery, radiation, hormone therapy, chemotherapy, and potentially clinical trials. Each treatment is chosen based on cancer type, stage, and the patient’s health. Surgery: The most common treatment, often involving a hysterectomy to remove the uterus, and sometimes the ovaries and fallopian tubes. Radiation
Quick Summery A recent study published in 2025 finds that cancer patients who quit smoking within six months of their diagnosis gain nearly one additional year of life. This finding challenges the misconception that quitting after cancer diagnosis is ineffective. The survival benefit applies to all cancer types and stages,
Precision Medicine, AI, and Global Collaboration in Cancer Care Take Center Stage in Berlin Dr. Christina Ng Van Tze, a respected Consultant Medical Oncologist and Medical Director at Onco Life Centre in Bangsar South, Kuala Lumpur, recently represented Malaysia at the ESMO Congress 2025 in Berlin. The global event brought
Quick Read Summary Choosing the right oncologist is one of the most crucial decisions in your cancer treatment journey. A specialist who understands your cancer type and treatment options can greatly influence your treatment success. Whether you need a medical, surgical, or radiation oncologist, finding a doctor who you trust
Quick Read Summary This article explores how real-world evidence (RWE) is transforming prostate cancer treatment, complementing traditional randomized controlled trials (RCTs). It discusses a major observational study comparing apalutamide and enzalutamide in metastatic castration-sensitive prostate cancer (mCSPC), showing a 23% lower mortality risk with apalutamide at 24 months. The piece
Quick Read Summary A new FDA-approved treatment combination of lurbinectedin and atezolizumab brings new hope to patients with extensive-stage small cell lung cancer (ES-SCLC). The combination, now a first-line maintenance therapy, provides a significant extension in survival and progression-free periods for patients whose disease has not progressed after initial therapy,
How Supportive Care Helps Patients Live Better Facing lung cancer can feel overwhelming, but understanding palliative care for lung cancer: managing symptoms and improving quality of life can make a big difference. Palliative care specialists focus on reducing symptoms, managing side effects, and helping patients feel more comfortable during treatment.
Understanding Cancer Care Specialists When you or a loved one is facing cancer, knowing your options and your care team is essential. Many people wonder, what are the three types of oncology? Understanding these specialties can help you make informed choices about your cancer treatment and support. What Is Oncology? Oncology is
First Oral HER2‑Targeted Therapy for Advanced NSCLC On August 8, 2025, the Food and Drug Administration (FDA) approved zongertinib (brand name Hernexeos), the first oral HER2-targeted therapy for patients with advanced non-small cell lung cancer (NSCLC) bearing HER2 mutations. This landmark approval marks a significant advancement in the treatment landscape
